Drug Profile
SIM 11057
Alternative Names: SIM-11057Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nanjing Medical University; Simcere Pharmaceutical Group
- Class Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Stroke in China
- 18 May 2011 Early research in Stroke in China (unspecified route)